Aktuelle News
News Funktionen
Weitere Funktionen
31 Juli 2014
Topotarget
Share capital and voting rights at July 31, 2014
24 Juli 2014
Topotarget
CORRECTION: Approval of Onxeo’s admission to secondary listing and trading on NASDAQ OMX Copenhagen
Topotarget
Approval of Onxeo’s admission to secondary listing and trading on NASDAQ OMX Copenhagen
23 Juli 2014
Topotarget
Cross-border merger of BioAlliance Pharma and Topotarget legally effective as of July 22, 2014
15 Juli 2014
Topotarget
CEO of Topotarget to resign
3 Juli 2014
Topotarget
FDA approval of Beleodaq™ (belinostat) for Injection
1 Juli 2014
Topotarget
Report pursuant to the Danish Securities Trading Act, Section 28a
Topotarget
New Articles of Association following capital increase
30 Juni 2014
Topotarget
Capital increase as a result of exercise of warrants
Topotarget
BioAlliance Pharma and Topotarget shareholders approve proposed cross-border merger to create Onxeo
27 Juni 2014
Topotarget
Passing on Extraordinary General Meeting
26 Mai 2014
Topotarget
Notice to Convene Extraordinary General Meeting
21 Mai 2014
Topotarget
Definitive Merger Plan between BioAlliance Pharma and Topotarget – Combined Entity to be Named Onxeo
8 Mai 2014
Topotarget
Topotarget announces interim report for the period January 1 – March 31, 2014
1 Mai 2014
Topotarget
Teleconference regarding interim report for the period January 1 – March 31, 2014
29 April 2014
Topotarget
HealthCap IV is committed to vote in support of Topotarget’s proposed merger with BioAlliance Pharma
28 April 2014
Topotarget
Major shareholder announcement
24 April 2014
Topotarget
Passing on Annual General Meeting
16 April 2014
Topotarget
Topotarget and BioAlliance Pharma enter into merger agreement to create a leading orphan oncology company
28 März 2014
Topotarget
Notice to convene Annual General Meeting 2014
27 März 2014
Topotarget
Topotarget announces financial results for the year ended Dec 31, 2013
26 März 2014
Topotarget
Topotarget confirms receipt of acceptance-to-file milestone payment
20 März 2014
Topotarget
Teleconference regarding annual report 2013
6 März 2014
Topotarget
Belinostat abstract for American Association for Cancer Research 2014
6 Februar 2014
Topotarget
FDA grants acceptance to file and Priority Review for Beleodaq™ (belinostat) NDA in PTCL
30 Januar 2014
Topotarget
Topotarget announces interim report for the period January 1 – December 31, 2013
23 Januar 2014
Topotarget
Teleconference regarding interim report for the period January 1 – December 31, 2013
10 Dezember 2013
Topotarget
New Drug Application for belinostat in relapsed or refractory PTCL submitted to the FDA in the USA
21 November 2013
Topotarget
Allowance of key belinostat patent in Europe
20 November 2013
Topotarget
Final results from CLN-14 study in STS